Kumagai, H., Kusaba, H., Yamanaka, T., Nio, K., Inadomi, K., Takayoshi, K., . . . Baba, E. (2018). A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy. Medicine (Baltimore).
Stile di citazione ChicagoKumagai, Hozumi, et al. "A Phase 2 Study of Fosaprepitant Combined With High-dose Dexamethasone for Japanese Cancer Patients Receiving Highly Emetogenic Chemotherapy." Medicine (Baltimore) 2018.
Citazione MLAKumagai, Hozumi, et al. "A Phase 2 Study of Fosaprepitant Combined With High-dose Dexamethasone for Japanese Cancer Patients Receiving Highly Emetogenic Chemotherapy." Medicine (Baltimore) 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.